Arkolith/Insider Trading/SONN/Form 4

Kenney Richard T

Chief Medical OfficerSonnet BioTherapeutics Holdings, Inc. (SONN) · full profile →Form 4 · filed May 20, 2021
Net Buying
Open-Market Buys
$16K
Open-Market Sells
$0
Net Open-Market Flow
$16K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2021Buy(P)10K$1.55$16K35K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905718-21-000714) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML